Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative ...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and …